Boston Scientific Corp.

BSX

$50.67

+29.0% last 12 months

Ken Griffin Holding value: $761 Million Ken Fisher Holding value: $192 Million Ray Dalio Holding value: $98.4 Million Steven Cohen Holding value: $90.3 Million Mario Gabelli Holding value: $3.24 Million Joel Greenblatt Holding value: $205 Thousand Jeremy Grantham Holding value: $0 Julian Robertson Holding value: $0 Jim Simons Holding value: $0 Tom Russo Holding value: $0 Daniel Loeb Holding value: $0 David Einhorn Holding value: $0 Chris Davis Holding value: $0 Stanley Druckenmiller Holding value: $0 George Soros Holding value: $0 David Tepper Holding value: $0

Market Cap

$74 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$34.98 - $54.17

The lowest and highest price in the last 52 weeks.

Price-Earnings Ratio

87.83x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Compare to
Market
Industry
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $74 Billion
Enterprise Value A measure of a company's total value. This includes market cap, cash, and debt. $82.5 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. $0.00 (0.0%)
1 Year Return Profit or loss of share price change plus dividend yield. +29.0%
52-Week High Highest share price in the last 52 weeks. $54.17
52-Week Low Lowest share price in the last 52 weeks. $34.98
Beta Beta indicates the volatility of a stock compared to the market. Higher beta means more volatile and thus potentially higher risk and return. 0.7
Outstanding Shares The number of shares the company has issued and are held by stockholders. 1.44 Billion
Avg 30 Day Volume The number of shares traded in the last 30 days. 9.43 Million

Valuation

Compare to
Market
Industry
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 87.83
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 41.97
Earnings per Share Earnings divided by outstanding shares. Higher EPS indicates greater value. $0.58
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 5.63
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 4.22
Enterprise Value to Revenue Enterprise value divided by revenue 6.32
Enterprise Value to EBIT Enterprise Value divided by EBIT 38.65
Total Debt to Enterprise Value Total debt divided by enterprise value 0.11
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.5

Profitability

Compare to
Market
Industry
Revenue Revenue is the sum of all cash flow into the company. $13 Billion
Gross Profit Gross profit is the profit after subtracting the costs of making and selling its products or the costs of providing its services. It indicates the efficiency of using their resources to produce goods or services. $9 Billion
EBIT Earnings before tax and interest payments. $2.13 Billion
Net Income Net Income is the profit after all expenses have been deducted from the total revenue. $843 Million
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 6.46%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. +209.3%
Return on Equity Equity divided by market cap. 4.66%
Return on Assets Indicates a company's profitability in relation to its total assets. 2.56%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 7.41%

Insider trades

No purchases

No sells

No purchases

No sells

No purchases

No sells

No purchases

No sells

Q3 2022 Q4 2022 Q1 2023 Q2 2023

About Boston Scientific Corp.

CEO: Michael Mahoney

Employees: 2,020

Industry: Surgical and Medical Instrument Manufacturing

Similar stocks

Edwards Lifesciences Corp
Edwards Lifesciences Corp
Stryker Corp.
Stryker Corp.
Merit Medical Systems, Inc.
Merit Medical Systems, Inc.
Medtronic Plc
Medtronic Plc
Teleflex Incorporated
Teleflex Incorporated
Angiodynamic Inc
Angiodynamic Inc
Conmed Corp.
Conmed Corp.

News

Boston Scientific: Meeting the Staff Shortage Crisis With Digital Solutions

Boston Scientific: Meeting the Staff Shortage Crisis With Digital Solutions

Originally published by Health Tech World onlineNORTHAMPTON, MA / ACCESSWIRE / June 6, 2023 / Right now, the global healthcare industry faces a worldwide sta...

Finanz Nachrichten Finanz Nachrichten, 1 day ago
3 Sizzling Growth Stocks to Buy for 2023’s Second Half

3 Sizzling Growth Stocks to Buy for 2023’s Second Half

As we enter the final month of the first half of the year, investors’ focus is on the next six months and beyond. As a result, you might be on the hunt for t...

InvestorPlace InvestorPlace, 7 days ago
Regulatory Hurdles Force Boston Scientific to Opt for Minority Stake in M.I. Tech

Regulatory Hurdles Force Boston Scientific to Opt for Minority Stake in M.I. Tech

Boston Scientific Corporation (NYSE: BSX ) is terminating its $230 million plan to buy a majority stake in M.I. Tech, a publicly traded Korean manufacturer a...

Benzinga Benzinga, 13 days ago
Here''s How Much $100 Invested In Boston Scientific 10 Years Ago Would Be Worth Today

Here''s How Much $100 Invested In Boston Scientific 10 Years Ago Would Be Worth Today

Boston Scientific (NYSE: BSX ) has outperformed the market over the past 10 years by 9.44% on an annualized basis producing an average annual return of 18.91...

Benzinga Benzinga, 14 days ago
Never miss a trade
To improve your user experience we use cookies.